What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His scientific interests lie mostly in Internal medicine, Oncology, Cancer, Breast cancer and Gynecology.
Internal medicine and Germline mutation are frequently intertwined in his study.
He has researched Oncology in several fields, including Cohort, Carcinoma, Prostate cancer, Family history and Risk assessment.
His Cancer research includes themes of Mutation, Immunology, Pathology, Genetic counseling and Genetic testing.
His Breast cancer research is multidisciplinary, incorporating perspectives in Ovarian cancer and Genotype.
His Gynecology research integrates issues from Proportional hazards model and Risk factor.
His most cited work include:
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial (1797 citations)
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients (1320 citations)
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer (1152 citations)
What are the main themes of his work throughout his whole career to date?
Mark E. Robson spends much of his time researching Internal medicine, Oncology, Breast cancer, Cancer and Germline.
His Internal medicine study often links to related topics such as Germline mutation.
As part of one scientific family, Mark E. Robson deals mainly with the area of Oncology, narrowing it down to issues related to the Metastatic breast cancer, and often PARP inhibitor.
He usually deals with Breast cancer and limits it to topics linked to Gynecology and Risk factor.
His research investigates the link between Cancer and topics such as Genetic testing that cross with problems in Genetic counseling and Family medicine.
The Germline study which covers Cancer research that intersects with Gene and Cancer predisposition.
He most often published in these fields:
- Internal medicine (60.00%)
- Oncology (54.67%)
- Breast cancer (47.81%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (60.00%)
- Oncology (54.67%)
- Breast cancer (47.81%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Breast cancer, Cancer and Germline.
His study in the fields of BRCA mutation, Metastatic breast cancer, Cohort and Stage under the domain of Internal medicine overlaps with other disciplines such as In patient.
His Oncology research incorporates themes from Pembrolizumab, Olaparib, Chemotherapy, CHEK2 and Triple-negative breast cancer.
His Breast cancer study incorporates themes from Odds ratio, Sequencing data, Mutation, Hazard ratio and Single-nucleotide polymorphism.
His study in Cancer is interdisciplinary in nature, drawing from both Exact test and Genetic testing.
His studies deal with areas such as Cancer research, Germline mutation, PALB2, Cancer predisposition and Renal cell carcinoma as well as Germline.
Between 2019 and 2021, his most popular works were:
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families (68 citations)
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. (57 citations)
- Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline. (35 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Mark E. Robson mainly investigates Internal medicine, Oncology, Cancer, Germline and Gene.
His Internal medicine research includes elements of CHEK2 and Guideline.
Mark E. Robson combines subjects such as Fertility preservation, BRCA mutation and Cyclophosphamide, Chemotherapy with his study of Oncology.
His Cancer study combines topics from a wide range of disciplines, such as First-degree relatives, Complex segregation analysis and Genetic testing.
Mark E. Robson has included themes like Germline mutation, PALB2 and Lung cancer in his Germline study.
His studies in Gene integrate themes in fields like Odds ratio, Family Cancer History and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
